Assessment of trans‐scleral iontophoresis delivery of lutein to the human retina

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Biophotonics

• Publication date

  2018-03-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1002/jbio.201700095PMID 28700128
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized Controlled Trial Comparing Transepithelial Corneal Cross-linking Using Iontophoresis with the Dresden Protocol in Progressive Keratoconus.

  2017cited by this paper
• Potential of agricultural fungicides for antifungal drug discovery

  2016cited by this paper
• Interrelation Between Oxidative Stress and Complement Activation in Models of Age-Related Macular Degeneration.

  2016cited by this paper
• LUTEIN REACHES THE RETINA FOLLOWING IONTOPHORESIS APPLICATION

  2016cited by this paper
• Photo-damage, photo-protection and age-related macular degeneration

  2015cited by this paper
• The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study.

  2015cited by this paper
• Evidence for including lutein and zeaxanthin in oral supplements for age-related macular degeneration.

  2014cited by this paper
• Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.

  2014cited by this paper
• Advances in ocular drug delivery: emphasis on the posterior segment

  2014cited by this paper
• Biomechanical changes in the human cornea after transepithelial corneal crosslinking using iontophoresis

  2014cited by this paper
• Evaluating in vivo delivery of riboflavin with coulomb-controlled iontophoresis for corneal collagen cross-linking: a pilot study.

  2014cited by this paper
• Why has Nature Chosen Lutein and Zeaxanthin to Protect the Retina?

  2014cited by this paper
• Evaluation of Ocular and General Safety Following Repeated Dosing of Dexamethasone Phosphate Delivered by Transscleral Iontophoresis in Rabbits

  2013cited by this paper
• Stress Reaction in Outer Segments of Photoreceptors after Blue Light Irradiation

  2013cited by this paper
• Evaluation of dexamethasone phosphate delivered by ocular iontophoresis for treating noninfectious anterior uveitis.

  2012cited by this paper
• Lutein: more than just a filter for blue light.

  2012cited by this paper
• Age-Related Eye Disease Study 2 (特集 臨床において必要なサプリメントの知識)

  2012cited by this paper
• Biological role of lutein in the light-induced retinal degeneration.

  2012cited by this paper
• Retinal light toxicity

  2011cited by this paper
• Global estimates of visual impairment: 2010

  2011cited by this paper
• Introducing Joe G. Hollyfield, the 2009 Recipient of the Proctor Medal.

  2010cited by this paper
• Iontophoretic transport of charged macromolecules across human sclera.

  2010cited by this paper
• Age-related macular degeneration: the molecular link between oxidative damage, tissue-specific inflammation and outer retinal disease: the Proctor lecture.

  2010cited by this paper
• Location of macular xanthophylls in the most vulnerable regions of photoreceptor outer-segment membranes.

  2010cited by this paper
• An Association Between the -1296C>T Polymorphism of the Tissue Inhibitor of Matrix Metalloproteinase-3 Gene and Age Related Macular Degeneration

  2010cited by this paper
• Barrier analysis of periocular drug delivery to the posterior segment.

  2010cited by this paper
• Retinal light damage: mechanisms and protection.

  2010cited by this paper
• The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis.

  2010cited by this paper
• Resonance Raman imaging of macular pigment distributions in the human retina.

  2008cited by this paper
• Examination of barriers and barrier alteration in transscleral iontophoresis.

  2008cited by this paper
• Age-related macular degeneration.

  2008cited by this paper
• Evidence of the early stage of porphyrin aggregation by enhanced Raman scattering and fluorescence spectroscopy.

  2007cited by this paper
• The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22.

  2007cited by this paper
• Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative.

  2006cited by this paper
• Iontophoresis: a non-invasive ocular drug delivery.

  2006cited by this paper
• Resonance Raman detection of carotenoid antioxidants in living human tissue.

  2005cited by this paper
• Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis.

  2005cited by this paper
• Influence of asymmetric donor-receiver ion concentration upon transscleral iontophoretic transport.

  2005cited by this paper
• Resonance Raman spectroscopic measurement of carotenoids in the skin and retina.

  2005cited by this paper
• Interactions between water soluble porphyrin-based star polymer and amino acids: spectroscopic evidence of molecular binding.

  2005cited by this paper
• Prevalence of age-related macular degeneration in the United States.

  2004cited by this paper
• Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis.

  2004cited by this paper
• The epidemiology of age-related macular degeneration.

  2004cited by this paper
• Macular pigment Raman detector for clinical applications.

  2004cited by this paper
• The science behind lutein.

  2004cited by this paper
• Resonance Raman measurement of macular carotenoids in the living human eye.

  2004cited by this paper
• Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study.

  2004cited by this paper
• Tolerance of Ocular Iontophoresis in Healthy Volunteers

  2003cited by this paper
• Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.

  2002cited by this paper
• Ocular aspirin distribution: a comparison of intravenous, topical, and coulomb-controlled iontophoresis administration.

  2002cited by this paper
• In vivo resonant Raman measurement of macular carotenoid pigments in the young and the aging human retina.

  2002cited by this paper
• Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes.

  2001cited by this paper
• Incidence and progression rates of age-related maculopathy: the Rotterdam Study.

  2001cited by this paper
• The role of oxidative stress in the pathogenesis of age-related macular degeneration.

  2000cited by this paper
• Iontophoresis: electrorepulsion and electroosmosis.

  2000cited by this paper
• Epidemiology of age-related macular degeneration.

  1999cited by this paper
• Oxidative damage and age-related macular degeneration.

  1999cited by this paper
• Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye.

  1998cited by this paper
• Raman detection of macular carotenoid pigments in intact human retina.

  1998cited by this paper
• Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study.

  1995cited by this paper
• Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration

  1994cited by this paper
• Spectral evidence of connected structures in liquid water: Effective Raman density of vibrational states.

  1993cited by this paper

• Non‐invasive and efficient diabetic retinal mitochondrial repair nanoplatform based on engineered endothelial mitochondrial‐derived vesicles with dynamic integrated stress response modulation

  2026cites this paper
• Scleral Iontophoresis for Targeted Lutein Delivery in intermediate stage dry AMD: Is this a New Frontier in age Macular degeneration?

  2026cites this paper
• Macular pigment optical density following lutein scleral iontophoresis in intermediate age-related macular degeneration: A six-month pilot study

  2026cites this paper
• Recent advances in iontophoresis-assisted microneedle devices for transdermal biosensing and drug delivery

  2025cites this paper
• Smart Nanocarriers for the Treatment of Retinal Diseases.

  2024cites this paper
• Advances in Ophthalmic Therapeutic Delivery: A Comprehensive Overview of Present and Future Directions.

  2024cites this paper
• Editorial: Eye in systemic diseases

  2023cites this paper
• Age-Related Macular Degeneration: An Exponentially Emerging Imminent Threat of Visual Impairment and Irreversible Blindness

  2023cites this paper
• Review: Emerging Eye-Based Diagnostic Technologies for Traumatic Brain Injury

  2022cites this paper
• Challenges in Age-Related Macular Degeneration: From Risk Factors to Novel Diagnostics and Prevention Strategies

  2022influential citation
• Overview of recent advancements in the iontophoretic drug delivery to various tissues and organs

  2021cites this paper
• Lutein-Loaded Solid Lipid Nanoparticles for Ocular Delivery: Statistical Optimization and Ex Vivo Evaluation

  2021cites this paper
• Lutein-Loaded Solid Lipid Nanoparticles for Ocular Delivery: Statistical Optimization and Ex Vivo Evaluation

  2021cites this paper
• Overcoming hurdles in iontophoretic drug delivery: is skin the only barrier? - an update.

  2019cites this paper
• Nonresonant Raman spectroscopy of isolated human retina samples complying with laser safety regulations for in vivo measurements

  2019cites this paper
• Stability, Cytotoxicity, and Retinal Pigment Epithelial Cell Binding of Hyaluronic Acid-Coated PLGA Nanoparticles Encapsulating Lutein

  2018cites this paper